 NEW YORK, June 3, 2021 PRNewswire -- Pomerantz LLP is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. Verrica or the Company NASDAQ: VRCA. Such investors are advised to contact Robert S. 